DEA Sample Clauses

POPULAR SAMPLE Copied 1 times
DEA. During the period commencing on January 1, 1997 and ending on the date hereof, with respect to Sellers or their Affiliates, to Seller's knowledge there have been no inspections, inspection reports or other correspondence from the Drug Enforcement Administration ("DEA") in which the DEA or any other Governmental or Regulatory Authority has asserted or alleged that the operations of Sellers with respect to the Facility is or was not or may not be in compliance with the federal Controlled Substances Act, as amended, or any similar law of any country or other jurisdiction.
View SourceView Similar (2)
DEA. Quota: VINTAGE shall secure all necessary quota from the United States Drug Enforcement Agency necessary to supply CORNERSTONE with Product(s).
View Source
DEA. Officers assigned to DEA shall be compensated at the rate of five percent (5%) over the Officer’s current base hourly rate for the length of the DEA assignment. Officers assigned to DEA will be issued a department cell phone and an unmarked department issued vehicle.
View Source
DEA. Rite Aid will certify that all Rite Aid pharmacies are properly and completely licensed in compliance with all applicable state and federal laws, regulations, and rules, and are licensed to order and dispense Schedule II Narcotic, Schedule II Nonnarcotic, Schedule III Narcotic, Schedule III Nonnarcotic, Schedule IV and Schedule V Rx Products. Such certification will be provided in the form of a list of each store and their respective state and Federal license numbers and expiration dates. On a monthly basis an updated list will be given to the McKesson representative resident at Rite Aid's headquarters. Any questions or problems regarding the licensing of any Rite Aid store will be sent to the attention of Jim ▇▇▇▇▇▇▇▇, ▇▇ contact can be made by phone at (717) ▇▇▇-▇▇▇▇.
View Source
DEA. Digital Equity Act is a U.S. federal law, enacted as part of the 2021 Infrastructure Investment and Jobs Act, aimed at addressing the digital divide by ensuring that all individuals and communities, particularly those historically underserved, have access to affordable, high- speed internet, digital skills training, and necessary devices to participate in a digital society and economy.
View Source

Related to DEA

  • Licensure The Contractor covenants that it has: (a) obtained all of the applicable licenses or permits, permanent, temporary or otherwise as required by Title 27 of the Virgin Islands Code; and (b) familiarized itself with the applicable provisions of Title 27 of the Virgin Islands Code pertaining to professions and occupations.

  • FDA As to each product subject to the jurisdiction of the U.S. Food and Drug Administration (“FDA”) under the Federal Food, Drug and Cosmetic Act, as amended, and the regulations thereunder (“FDCA”) that is manufactured, packaged, labeled, tested, distributed, sold, and/or marketed by the Company or any of its Subsidiaries (each such product, a “Pharmaceutical Product”), such Pharmaceutical Product is being manufactured, packaged, labeled, tested, distributed, sold and/or marketed by the Company in compliance with all applicable requirements under FDCA and similar laws, rules and regulations relating to registration, investigational use, premarket clearance, licensure, or application approval, good manufacturing practices, good laboratory practices, good clinical practices, product listing, quotas, labeling, advertising, record keeping and filing of reports, except where the failure to be in compliance would not have a Material Adverse Effect. There is no pending, completed or, to the Company's knowledge, threatened, action (including any lawsuit, arbitration, or legal or administrative or regulatory proceeding, charge, complaint, or investigation) against the Company or any of its Subsidiaries, and none of the Company or any of its Subsidiaries has received any notice, warning letter or other communication from the FDA or any other governmental entity, which (i) contests the premarket clearance, licensure, registration, or approval of, the uses of, the distribution of, the manufacturing or packaging of, the testing of, the sale of, or the labeling and promotion of any Pharmaceutical Product, (ii) withdraws its approval of, requests the recall, suspension, or seizure of, or withdraws or orders the withdrawal of advertising or sales promotional materials relating to, any Pharmaceutical Product, (iii) imposes a clinical hold on any clinical investigation by the Company or any of its Subsidiaries, (iv) enjoins production at any facility of the Company or any of its Subsidiaries, (v) enters or proposes to enter into a consent decree of permanent injunction with the Company or any of its Subsidiaries, or (vi) otherwise alleges any violation of any laws, rules or regulations by the Company or any of its Subsidiaries, and which, either individually or in the aggregate, would have a Material Adverse Effect. The properties, business and operations of the Company have been and are being conducted in all material respects in accordance with all applicable laws, rules and regulations of the FDA. The Company has not been informed by the FDA that the FDA will prohibit the marketing, sale, license or use in the United States of any product proposed to be developed, produced or marketed by the Company nor has the FDA expressed any concern as to approving or clearing for marketing any product being developed or proposed to be developed by the Company.

  • Alcohol and Drug Testing Employee agrees to comply with and submit to any Company program or policy for testing for alcohol abuse or use of drugs and, in the absence of such a program or policy, to submit to such testing as may be required by Company and administered in accordance with applicable law and regulations.

  • Designated Prescription Drug Prescribers and Pharmacies We may limit your selection of a pharmacy to a single pharmacy location and/or a single prescribing provider or practice. Those members subject to this designation include, but are not limited to, members that have a history of: • being prescribed prescription drugs by multiple providers; • having prescriptions drugs filled at multiple pharmacies; • being prescribed certain long-acting opioids and other controlled substances, either in combination or separately, that suggests a need for monitoring due to: o quantities dispensed; o daily dosage range; or o the duration of therapy exceeds reasonable and established thresholds.